Inventor · Melbourne, AU

Felix Meiser

19Patents

4h-index

12Co-inventors

53Inventor score

Filing activity: Jun 29, 2007 → Jun 22, 2018

Most-cited inventions

Patent	Title	Area	Cited by	Status
US8734847B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	6	Active
US9095496B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	6	Active
US8808751B2	Methods for the preparation of biologically active compounds in nanoparticulate form	Human Necessities	5	Active
US9089471B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	5	Active
US8735450B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	4	Active
US9173854B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US9180096B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US9186328B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US10022303B2	Inhalable pharmaceutical compositions	Human Necessities	2	Active
US9017721B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US8992982B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	2	Active
US8999387B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US8679544B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	2	Active
US9849111B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	1	Active
US9522135B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	1	Active
US9180095B2	Formulation of diclofenac	Emerging Cross-Sectional Technologies	0	Active
US10983132B2	Method and product for testing response to oral glucose load	Physics	0	Active
US11103456B2	Methods for the preparation of biologically active compounds in nanoparticulate form	Human Necessities	0	Active
US10172828B2	Formulation of indomethacin	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.